Background
Blacks are more likely than whites to be diagnosed with colorectal cancer and die of their disease. The extent to which genetic or biologic factors versus disparities in screening rates explain this variance remains controversial.
Objective
To define the prevalence and location of presymptomatic advanced colorectal neoplasia (ACN) among whites and blacks undergoing screening colonoscopy controlling for other epidemiologic determinants of risk.
Design
Cross-sectional survey between March 22, 2005 and January 31, 2012.
Setting
Urban, open-access, academic, safety net hospital in Massachusetts.
Participants
Asymptomatic, average-risk whites (n=1172) and blacks (n=1681) 50 to 79 years of age presenting for screening colonoscopy.
Measurements
Adjusted prevalence and location of ACN, defined as a tubular adenoma ≥ 10 mm in size, any adenoma with villous features or high-grade dysplasia, any dysplastic serrated lesion, or invasive cancer.
Results
The prevalence of ACN was higher among whites than blacks (6.8% vs. 5.0%; P=0.039) but varied by sex (white versus black men, 9.3% vs. 5.7%; white vs. black women, 3.5% vs. 4.3%; P for interaction =0.034). After controlling for exposure to multiple risk factors, black men were 41% less likely than white men (adjusted odds ratio [aOR], 0.59; 95% confidence intervals [CI], 0.39–0.89) to have ACN; conversely, no significant differences were observed for women (aOR, 1.32; 95% CI, 0.73–2.40). Among individuals with ACN, blacks a higher percentage of proximal disease (52% vs. 39%) after adjustment for age and sex (P=0.055).
Limitations
Single institution study; inadequate statistical power for subgroup analyses; recall bias.
Conclusions
Black men are less likely than white men to have ACN at screening colonoscopy in a safety net health care setting. These findings suggest that disparities in access to screening and differential exposure to modifiable risk factors rather than genetic or biologic factors are largely responsible for the higher incidence of CRC among black men. Genetic or biologic factors, however may explain the predilection for proximal disease.
Primary Funding Source
National Cancer Institute